Hongliang G. Li
Jiefang Road 238
Wuhan, 430060, China
Wuhan, 430060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
TNIP3 protects against pathological cardiac hypertrophy by stabilizing STAT1.
Journal: Cell death & disease
Published: December 29, 2023
Targeted imaging of pulmonary fibrosis by a cyclic peptide LyP-1.
Journal: Scientific reports
Published: July 27, 2023
Global and Regional Trends and Projections of Infective Endocarditis-Associated Disease Burden and Attributable Risk Factors from 1990 to 2030.
Journal: Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih
Published: November 02, 2022
Recent updates on targeting the molecular mediators of NAFLD.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: September 07, 2022
Association Between Lipid Profiles and Left Ventricular Hypertrophy: New Evidence from a Retrospective Study.
Journal: Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih
Published: March 08, 2022
Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data.
Journal: Respiratory research
Published: July 20, 2021
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
Journal: World journal of gastroenterology
Published: January 14, 2019
Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases.
Journal: Annual review of pathology
Published: September 20, 2018
Tollip Negatively Regulates Vascular Smooth Muscle Cell-Mediated Neointima Formation by Suppressing Akt-Dependent Signaling.
Journal: Journal of the American Heart Association
Published: June 12, 2018
Last Updated: 09/26/2026